Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.13 - $12.25 $230,749 - $903,094
-73,722 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$9.54 - $14.26 $15,798 - $23,614
-1,656 Reduced 2.2%
73,722 $830,000
Q4 2021

Feb 14, 2022

SELL
$7.34 - $10.25 $41,162 - $57,482
-5,608 Reduced 6.92%
75,378 $638,000
Q3 2021

Nov 12, 2021

BUY
$8.05 - $13.29 $48,799 - $80,563
6,062 Added 8.09%
80,986 $763,000
Q2 2021

Aug 16, 2021

BUY
$11.76 - $16.85 $388,938 - $557,280
33,073 Added 79.03%
74,924 $919,000
Q1 2021

May 17, 2021

SELL
$14.21 - $25.3 $1.64 Million - $2.92 Million
-115,235 Reduced 73.36%
41,851 $667,000
Q4 2020

Feb 16, 2021

SELL
$14.8 - $20.37 $120,531 - $165,893
-8,144 Reduced 4.93%
157,086 $2.4 Million
Q3 2020

Nov 16, 2020

BUY
$11.74 - $22.0 $1.72 Million - $3.22 Million
146,181 Added 767.39%
165,230 $3.07 Million
Q2 2020

Aug 14, 2020

BUY
$5.67 - $15.86 $108,007 - $302,117
19,049 New
19,049 $231,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $33M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.